Safety and Efficacy Study in Patients With Retinitis Pigmentosa Due to Mutations in PDE6B Gene
Clinical trial NCT03328130 · TERMINATED
Trial details
- NCT number
- NCT03328130
- Sponsor
- eyeDNA Therapeutics
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-06
- Primary completion
- 2025-06-30
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.